1:
Molecular response to aromatase inhibitor treatment in primary breast cancer.
Mackay A, Urruticoechea A, Dixon JM, Dexter T, Fenwick K, Ashworth A, Drury S, Larionov A, Young O, White S, Miller WR, Evans DB, Dowsett M.
Breast Cancer Res. 2007;9(3):R37.
PMID: 17555561 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
2:
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole.
Miller WR, Larionov AA, Renshaw L, Anderson TJ, White S, Murray J, Murray E, Hampton G, Walker JR, Ho S, Krause A, Evans DB, Dixon JM.
Pharmacogenet Genomics. 2007 Oct;17(10):813-26.
PMID: 17885619 [PubMed - indexed for MEDLINE]
Related Articles
8:
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
Polychronis A, Sinnett HD, Hadjiminas D, Singhal H, Mansi JL, Shivapatham D, Shousha S, Jiang J, Peston D, Barrett N, Vigushin D, Morrison K, Beresford E, Ali S, Slade MJ, Coombes RC.
Lancet Oncol. 2005 Jun;6(6):383-91. Erratum in: Lancet Oncol. 2005 Jun;6(6):357.
PMID: 15925816 [PubMed - indexed for MEDLINE]
Related Articles
10:
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.
Torrisi R, Bagnardi V, Pruneri G, Ghisini R, Bottiglieri L, Magni E, Veronesi P, D'Alessandro C, Luini A, Dellapasqua S, Viale G, Goldhirsch A, Colleoni M.
Br J Cancer. 2007 Sep 17;97(6):802-8. Epub 2007 Aug 21.
PMID: 17712311 [PubMed - indexed for MEDLINE]
Related Articles
11:
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.
J Clin Oncol. 2007 Feb 10;25(5):486-92. Epub 2007 Jan 2.
PMID: 17200148 [PubMed - indexed for MEDLINE]
Related Articles
19:
An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.
Rose C, Vtoraya O, Pluzanska A, Davidson N, Gershanovich M, Thomas R, Johnson S, Caicedo JJ, Gervasio H, Manikhas G, Ben Ayed F, Burdette-Radoux S, Chaudri-Ross HA, Lang R.
Eur J Cancer. 2003 Nov;39(16):2318-27.
PMID: 14556923 [PubMed - indexed for MEDLINE]
Related Articles